EYENOVIA, INC. (43)
Browse by Contract Category
Contracts
-
Third Amendment to Loan and Security Agreement, dated as of May 6, 2022, by and between Eyenovia, Inc. and Silicon Valley Bank
(Filed With SEC on May 12, 2022)
-
Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and Michael Rowe
(Filed With SEC on March 30, 2022)
-
Description of Securities
(Filed With SEC on March 30, 2022)
-
Settlement Agreement, dated as of February 4, 2022
(Filed With SEC on February 7, 2022)
-
Amendment 2 to the Exclusive License Agreement between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., effective as of May 2021
(Filed With SEC on November 12, 2021)
-
Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and John Gandolfo
(Filed With SEC on March 30, 2022)
-
Addendum to Executive Employment Agreement, dated March 10, 2022, by and between the Company and Tsontcho Ianchulev
(Filed With SEC on March 30, 2022)
-
Director Compensation Policy
(Filed With SEC on March 30, 2022)
-
Form of Purchase Agreement between the Company and the Purchaser, dated March 3, 2022
(Filed With SEC on March 9, 2022)
-
Form of Warrant
(Filed With SEC on March 9, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 9, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on March 7, 2022)
-
Form of Purchase Agreement between the Company and the Purchaser, dated March 3, 2022
(Filed With SEC on March 7, 2022)
-
Form of Warrant
(Filed With SEC on March 7, 2022)
-
Waiver Agreement, dated as of November 30, 2021, by and between the Company and SVB
(Filed With SEC on December 3, 2021)
-
First Amendment to Loan and Security Agreement between Eyenovia, Inc. and Silicon Valley Bank, dated September 29, 2021
(Filed With SEC on November 12, 2021)
-
Amendment 1 to the License Agreement between Eyenovia, Inc. and Arctic Vision (Hong Kong) Limited, dated September 14, 2021
(Filed With SEC on November 12, 2021)
-
Amended and Restated 2018 Omnibus Stock Incentive Plan, As Amended
(Filed With SEC on August 12, 2021)
-
Sales Agreement, dated as of May 14, 2021, between Eyenovia, Inc. and SVB Leerink LLC
(Filed With SEC on May 14, 2021)
-
Form of Warrant issued by the Company to Silicon Valley Bank
(Filed With SEC on May 10, 2021)
-
Loan and Security Agreement, dated as of May 7, 2021, by and between the Company and Silicon Valley Bank
(Filed With SEC on May 10, 2021)
-
Description of Securities
(Filed With SEC on March 30, 2021)
-
Amendment to Executive Employment Agreement, dated February 1, 2021, by and between the Company and Michael M. Rowe
(Filed With SEC on February 3, 2021)
-
License Agreement by and between Eyenovia, Inc. and Bausch Health Ireland Limited, dated October 9, 2020
(Filed With SEC on October 13, 2020)
-
Underwriting Agreement, dated August 19, 2020, by and between Eyenovia, Inc. and William Blair & Company, L.L.C. as representative of the several underwriters named therein
(Filed With SEC on August 21, 2020)
-
License Agreement by and between Eyenovia, Inc. and Artic Vision (Hong Kong) Limited, dated August 10, 2020
(Filed With SEC on August 14, 2020)
-
Letter Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated August 10, 2020
(Filed With SEC on August 14, 2020)
-
Amendment to the Exclusive License Agreement by and between Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd., dated April 8, 2020
(Filed With SEC on August 14, 2020)
-
Eyenovia, Inc. Amended and Restated 2018 Omnibus Stock Incentive Plan
(Filed With SEC on July 2, 2020)
-
Promissory Note and Agreement dated May 3, 2020
(Filed With SEC on May 8, 2020)
-
Description of Securities
(Filed With SEC on March 30, 2020)
-
Form of Class A Warrant issued on March 24, 2020
(Filed With SEC on March 25, 2020)
-
Securities Purchase Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein
(Filed With SEC on March 25, 2020)
-
Form of Class B Warrant issued on March 24, 2020
(Filed With SEC on March 25, 2020)
-
Registration Rights Agreement, dated March 23, 2020, between Eyenovia, Inc. and the investors named therein
(Filed With SEC on March 25, 2020)
-
Underwriting Agreement, dated July 11, 2019, by and among Eyenovia, Inc. and Oppenheimer & Co. Inc., as representative of the several underwriters named therein
(Filed With SEC on July 15, 2019)
-
Eyenovia, Inc. 2018 Omnibus Stock Incentive Plan, as amended
(Filed With SEC on June 12, 2019)
-
Executive Employment Agreement, dated February 15, 2019, by and between the Company and Michael Rowe
(Filed With SEC on February 19, 2019)
-
Executive Employment Agreement, dated February 15, 2019, by and between the Company and Luke Clauson
(Filed With SEC on February 19, 2019)
-
Executive Employment Agreement, dated February 15, 2019, by and between the Company and John Gandolfo
(Filed With SEC on February 19, 2019)
-
Executive Employment Agreement, dated February 15, 2019, by and between the Company and Jennifer Clasby
(Filed With SEC on February 19, 2019)
-
Form of Nondisclosure, Assignment of Inventions and Noncompetition Agreement
(Filed With SEC on February 19, 2019)
-
Executive Employment Agreement, dated February 15, 2019, by and between the Company and Tsontcho Ianchulev
(Filed With SEC on February 19, 2019)